A study on metabolic characteristics and metabolic markers of gastrointestinal tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A study on metabolic characteristics and metabolic markers of gastrointestinal tumors

Published:2023-09-13 Issue:1 Volume:24 Page:
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Cong Shan¹,Bai shanshan²,Zhang Minghao³,Bi yanfang⁴,Wang yu¹,Jin shi¹,He hui¹^ORCID

Affiliation:

1. Department of Laparoscopic Surgery, the First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China

2. Department of Ultrasound, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China

3. Department of Vascular Interventional, Affiliated Hongqi Hospital of Mudanjiang Medical College, Mudanjiang, China

4. Department of Nursing, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China

Funder

the Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2023.2255369

Reference46 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Expansion of cancer care and control in countries of low and middle income: a call to action

3. Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal Tumors

4. Tumor-Reactive CD8+ T Cells in Metastatic Gastrointestinal Cancer Refractory to Chemotherapy

5. Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP